These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16466531)

  • 21. Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men.
    Rodprasert W; Toppari J; Virtanen HE
    Front Endocrinol (Lausanne); 2021; 12():706532. PubMed ID: 34690925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does a testicular dysgenesis syndrome exist?
    Akre O; Richiardi L
    Hum Reprod; 2009 Sep; 24(9):2053-60. PubMed ID: 19443456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent trends in male reproductive disorders].
    Iwamoto T; Nozawa S
    Nihon Rinsho; 2000 Dec; 58(12):2514-20. PubMed ID: 11187747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contaminant-induced feminization and demasculinization of nonmammalian vertebrate males in aquatic environments.
    Milnes MR; Bermudez DS; Bryan TA; Edwards TM; Gunderson MP; Larkin IL; Moore BC; Guillette LJ
    Environ Res; 2006 Jan; 100(1):3-17. PubMed ID: 15913597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testicular dysgenesis syndrome: foetal origin of adult reproductive problems.
    Wohlfahrt-Veje C; Main KM; Skakkebaek NE
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):459-65. PubMed ID: 19222487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leydig cell clustering and Reinke crystal distribution in relation to hormonal function in adult patients with testicular dysgenesis syndrome (TDS) including cryptorchidism.
    Soerensen RR; Johannsen TH; Skakkebaek NE; Rajpert-De Meyts E
    Hormones (Athens); 2016 Oct; 15(4):518-526. PubMed ID: 28222406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.
    Bonde JP; Flachs EM; Rimborg S; Glazer CH; Giwercman A; Ramlau-Hansen CH; Hougaard KS; Høyer BB; Hærvig KK; Petersen SB; Rylander L; Specht IO; Toft G; Bräuner EV
    Hum Reprod Update; 2016 Dec; 23(1):104-125. PubMed ID: 27655588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible effects of endocrine disruptors on male reproductive function.
    Mori C
    Kaibogaku Zasshi; 2001 Aug; 76(4):361-8. PubMed ID: 11577437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endocrine disruptor compounds and their role in the developmental programming of the reproductive axis].
    Guzmán C; Zambrano E
    Rev Invest Clin; 2007; 59(1):73-81. PubMed ID: 17569302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between phthalates and testicular dysgenesis syndrome].
    Chen GR; Dong L; Ge RS; Hardy MP
    Zhonghua Nan Ke Xue; 2007 Mar; 13(3):195-200. PubMed ID: 17393778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phthalate-induced testicular dysgenesis syndrome: Leydig cell influence.
    Hu GX; Lian QQ; Ge RS; Hardy DO; Li XK
    Trends Endocrinol Metab; 2009 Apr; 20(3):139-45. PubMed ID: 19278865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From gonocytes to testicular cancer: the role of impaired gonadal development.
    Rajpert-de Meyts E; Hoei-Hansen CE
    Ann N Y Acad Sci; 2007 Dec; 1120():168-80. PubMed ID: 18184914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Brief Review of the Link between Environment and Male Reproductive Health: Lessons from Studies of Testicular Germ Cell Cancer.
    Skakkebaek NE
    Horm Res Paediatr; 2016; 86(4):240-246. PubMed ID: 26871895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of testicular dysgenesis syndrome in the dog.
    Grieco V; Riccardi E; Veronesi MC; Giudice C; Finazzi M
    Theriogenology; 2008 Jul; 70(1):53-60. PubMed ID: 18423567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Testicular dysgenesis syndrome: an update].
    Xu ZM; Tang DX
    Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1113-6. PubMed ID: 21348205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phthalate ester toxicity in Leydig cells: developmental timing and dosage considerations.
    Ge RS; Chen GR; Tanrikut C; Hardy MP
    Reprod Toxicol; 2007; 23(3):366-73. PubMed ID: 17258888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testis and antler dysgenesis in sitka black-tailed deer on Kodiak Island, Alaska: Sequela of environmental endocrine disruption?
    Veeramachaneni DN; Amann RP; Jacobson JP
    Environ Health Perspect; 2006 Apr; 114 Suppl 1(Suppl 1):51-9. PubMed ID: 16818246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations.
    Skakkebaek NE; Rajpert-De Meyts E; Jørgensen N; Main KM; Leffers H; Andersson AM; Juul A; Jensen TK; Toppari J
    Int J Androl; 2007 Aug; 30(4):198-204; discussion 204-5. PubMed ID: 17705804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel androgen receptor mutation in a family with multiple components compatible with the testicular dysgenesis syndrome.
    Lottrup G; Jørgensen A; Nielsen JE; Jørgensen N; Duno M; Vinggaard AM; Skakkebæk NE; Rajpert-De Meyts E
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2223-9. PubMed ID: 23589523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies.
    Storgaard L; Bonde JP; Olsen J
    Reprod Toxicol; 2006 Jan; 21(1):4-15. PubMed ID: 16005180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.